UnitedHealth Group is being investigated by the Justice Department for possible criminal Medicare fraud, The Wall Street Journal reported, citing people familiar with the matter. The healthcare-fraud ...

Shares of UnitedHealth Group fell after The Wall Street Journal reported that the Justice Department is investigating the company for possible criminal Medicare fraud. The stock fell 5.1%, to $292.40, ...

Free cashflow rose by 48% to NZ$506.7 million but Xero did not declare a dividend. Xero said it expects an operating expense ratio of about 71.5% in fiscal 2026, with the first-half ratio sitting ...

Biohaven shares slipped after the Food and Drug Administration extended the Prescription Drug User Fee Act date for the biopharmaceutical company's troriluzole application by three months. The stock ...

Dow Jones Top Company Headlines at 7 PM ET: Cisco Systems Boosts Outlook After Posting Higher Profit, Sales | Dick’s ... Cisco Systems Boosts Outlook After Posting Higher Profit, Sales The ...

The Organization of the Petroleum Exporting Countries trimmed its economic growth outlook and kept its oil demand forecast steady as it prepares to accelerate production. Trump later heaped praise on ...

AI boosters cling to fanciful forecasts - even if meaningful revenue and productivity has yet to materialize . Nobel Laureate Robert Solow once sa ...

Nvidia's partnership with Saudi Arabia's Humain could help offset some of its revenue losses in China, analysts said The artificial-intelligence trade is back on, as new deals between Saudi Arabia and ...

Barclays analysts now expect high-yield spreads will "marginally" widen by year-end, to 325 to 350 basis points. That's tighter than their forecast in mid-March, when they anticipated an increase to ...

Shares of Foot Locker Inc. rocketed 65% higher after hours on Wednesday after the Wall Street Journal reported that Dick's Sporting Goods Inc. was close to a deal to buy the struggling sneaker chain.

Merck has received approval from the Food and Drug Administration for Welireg, its oral inhibitor for patients with certain rare types of neuroendocrine tumors. The company said Wednesday the ...